First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone

Authors

Aaron Roberto
Aileen Lorenzo, New York Medical College
Jonathan Young
Abhishek Mohan
Subhash Pinnaka, New York Medical College
Kyle Lapidus

Author Type(s)

Resident/Fellow

Document Type

Article

Publication Date

2016

Department

Psychiatry and Behavioral Sciences

Abstract

Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient.

Comments

Please see the work itself for the complete list of authors.

Recommended Citation

Roberto, A. J., Lorenzo, A., Li, K. J., Young, J., Mohan, A., Pinnaka, S., & Lapidus, K. A. (2016). First-episode of synthetic cannabinoid-induced psychosis in a young adult, successfully managed with hospitalization and risperidone. Case Reports in Psychiatry, 2016, Art. ID: 7257489, 4 pages. doi:10.1155/2016/7257489

Publisher's Statement

Originally published in Case Reports in Psychiatry. Licensed under CC-BY 4.0. https://doi.org/10.1155/2016/7257489